Lam Research Corporation March quarter 2023 financial results April 19, 2023 -- 1 of 24 -- L A M R E S E A R C H Confidential – Limited Access and Use Cautionary statement regarding forward-looking statements This presentation and the accompanying discussion contain “forward-looking statements” under U.S. securities laws. Forward-looking statements include any statements that are not statements of historical fact. Examples of forward-looking statements include, but are not limited to: (1) anticipated business, balance sheet, cash flow and financial measures and results, including guidance, whether on a GAAP or non-GAAP basis; (2) economic, market, industry and industry segment expectations; (3) product performance and changes in market share or customer demands; (4) our ability to successfully execute business, capital allocation, product and growth plans or strategies, or otherwise deliver value for customers and stockholders; (5) the impact and expected duration of supply chain disruptions, and our ability to mitigate them; (6) the impact of the COVID-19 pandemic on our operations and financial results, and our ability to mitigate operational and business impacts caused by it; and (7) the impact of trade regulations, export controls and trade disputes. Forward-looking statements speak only as of the date they are made and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed, including: trade regulations, export controls, trade disputes and other geopolitical tensions may inhibit our ability to sell our products; business, political and/or regulatory conditions in the consumer electronics industry, the semiconductor industry and the overall economy may deteriorate or change; the actions of our customers and competitors may be inconsistent with our expectations; supply chain cost increases and other inflationary pressures have impacted and are expected to continue to impact our profitability; supply chain disruptions or manufacturing capacity constraints may limit our ability to manufacture and sell our products; the severity, magnitude and duration of the COVID–19 pandemic (and the related governmental, public health, business and community responses to it), and their impacts on our business, results of operations and financial condition, are evolving and are highly uncertain and unpredictable; and widespread outbreaks of illness may impact our operations and revenue in affected areas; as well as the other factors discussed in our filings with the Securities and Exchange Commission (“SEC”), including specifically the Risk Factors described in our annual report on Form 10–K for the fiscal year ended June 26, 2022 and our quarterly report on Form 10-Q for the quarter ended December 25, 2022. You should not place undue reliance on forward-looking statements. Lam undertakes no obligation to update any forward-looking statements. -- 2 of 24 -- L A M R E S E A R C H Confidential – Limited Access and Use $1.7B R&D* ~18,700 EMPLOYEES A s of Marc h 26, 2023 $19.0B REVENUE* 10 PRIMARY LOCATIONS + Fremont, CA + Livermore, CA + Sherwood, OR + Tualatin, OR + Springfield, OH + Eaton, OH + Villach, Austria + Gyeonggi-do, Korea + Taoyuan City, Taiwan + Batu Kawan, Malaysia AWARDS AND RECOGNITION 100 Most Sustainable U.S. Companies Barron’s World’s Most Ethical Companies Ethisphere America’s Best Employers for Diversity Forbes World’s Most Admired Companies Fortune Best Places to Work For LGBTQ+ Equality Human Rights Campaign Dow Jones Sustainability Index North America S&P Global A global leader in wafer fabrication equipment and services since 1980 *Figures as of calendar year 2022 -- 3 of 24 -- L A M R E S E A R C H Business review & industry outlook Tim Archer President and Chief Executive Officer -- 4 of 24 -- L A M R E S E A R C H Confidential – Limited Access and Use March quarter performance Revenue of $3.87B and EPS of $6.99 exceed midpoint of guidance range Record quarter of Foundry systems revenue with solid progress in leading-edge & specialty technology segments Investing in long-term technology roadmaps while managing spending and strengthening operational processes EPS = earnings per share EPS calculated on a non-GAAP basis. Reconciliations of U.S GAAP results to non-GAAP results can be found at the end of this presentation. -- 5 of 24 -- L A M R E S E A R C H Confidential – Limited Access and Use WFE outlook CY 2023 WFE expected to be in the low to mid $70B range Additional weakness from memory customers, partially offset by domestic China-related demand across logic and memory • Memory customers limiting bit output to drive down elevated inventory • Expect memory spending down approximately 50% from 2022 led by NAND Current memory spending unsustainable to support long-term NAND and DRAM bit demand growth Memory leadership position and large installed base provide valuable platform for growth when customers ramp to normal levels WFE = wafer fabrication equipment CY = calendar year -- 6 of 24 -- L A M R E S E A R C H Confidential – Limited Access and Use Rising complexity fundamental to Lam’s opportunity Lam has a leading share position with a broadening product footprint as EUV adoption scales Our etch and deposition solutions enhance productivity by creating smooth patterns and reducing line width roughness Lam’s dry resist technologies gaining momentum with multiple customer adoptions Patterning with EUV EUV = extreme ultraviolet -- 7 of 24 -- L A M R E S E A R C H Confidential – Limited Access and Use Rising complexity fundamental to Lam’s opportunity Complex 3D architecture plays to Lam’s strengths Close to one-billion-dollar incremental opportunity Lam’s ALD/ALE capabilities, including Argos®, Prevos®, and Selis® selective etch tools and ALD low k spacer and nitride films, are winning at multiple customers Gate-all-around ALD = atomic layer deposition ALE = atomic layer etching -- 8 of 24 -- L A M R E S E A R C H Near-term focus on expenses and operations Prioritization of R&D investments tied to critical manufacturing inflections Installed base has grown ~40% since last downturn Strong position to outperform when WFE growth resumes Positioned for long-term outperformance -- 9 of 24 -- L A M R E S E A R C H Confidential – Limited Access and Use March quarter 2023 financial results & June quarter 2023 outlook Doug Bettinger Executive Vice President and Chief Financial Officer -- 10 of 24 -- L A M R E S E A R C H Confidential – Limited Access and Use QMAR’23 REVENUE QMAR’23 DEFERRED REVENUE* March quarter highlights $3.87B QDec'22 revenue: $5.28B $2.0B QDec'22 deferred revenue: $2.0B *Lam’s deferred revenue balance does not include shipments to customers in Japan, to whom title does not transfer until customer acceptance. Estimated future revenue from shipments to customers in Japan was approximately $212M as of March 26, 2023 and $379M as of December 25, 2022. -- 11 of 24 -- L A M R E S E A R C H Confidential – Limited Access and Use China 22% Korea 22% Taiwan 18% US 16% Japan 10% Europe 8% SEA 4% REVENUE BY REGION March quarter revenue mix NVM 23% DRAM 9% Foundry 46% Logic/other 22% System revenue segments* Memory 32% Record level of Foundry revenue dollars NVM = Non-Volatile Memory *Systems revenue includes equipment and equipment upgrade sales from etch, deposition, clean, and our Reliant® product line -- 12 of 24 -- L A M R E S E A R C H Confidential – Limited Access and Use QMAR’23 CSBG REVENUE Customer Support Business Group $1.61B QDec'22 CSBG revenue: $1.73B QMar'22 CSBG revenue: $1.41B -- 13 of 24 -- L A M R E S E A R C H Confidential – Limited Access and Use QMAR'23 QDEC'22 Revenue $3,870M $5,278M Non-GAAP gross margin* 44.0% 45.1% Non-GAAP operating expenses* $608M $686M Non-GAAP operating income* $1,097M $1,695M Non-GAAP operating income as a percentage of revenue* 28.3% 32.1% Non-GAAP other expense, net* $8M $38M U.S. GAAP diluted EPS $6.01 $10.77 Non-GAAP diluted EPS* $6.99 $10.71 Diluted share count 135M 136M March quarter financial results *A reconciliation of U.S. GAAP results to non-GAAP results can be found at the end of this presentation. -- 14 of 24 -- L A M R E S E A R C H Confidential – Limited Access and Use Key balance sheet and financial metrics QMAR'23 QDEC'22 Total consolidated gross cash balance $5,620M $4,839M Account receivables, net $3,262M $4,070M DSO 77 days 70 days Inventories $4,882M $4,820M Inventory turns 1.9 2.4 Deferred revenue* $2,003M $1,984M Capital expenditures $119M $163M Equity compensation expense $74M $73M Amortization expense $14M $12M Depreciation expense $78M $73M Share repurchases $483M $483M Cash dividends $234M $236M Headcount ~18,700 ~19,200 *Lam’s deferred revenue balance does not include shipments to customers in Japan, to whom title does not transfer until customer acceptance. Estimated future revenue from shipments to customers in Japan was approximately $212M as of March 26, 2023 and $379M as of December 25, 2022. -- 15 of 24 -- L A M R E S E A R C H Confidential – Limited Access and Use $3.1B +/- $300M Revenue 44.0% +/- 1% Non-GAAP gross margin* 25.5% +/- 1% Non-GAAP operating margin* $5.00 +/- $0.75 Non-GAAP earnings per share* June 2023 quarter guidance A reconciliation of U.S. GAAP projected results to non-GAAP projected results can be found at the end of this presentation. *Based on a diluted share count of approximately 134 million shares. -- 16 of 24 -- L A M R E S E A R C H Confidential – Limited Access and Use Q&A -- 17 of 24 -- L A M R E S E A R C H Confidential – Limited Access and Use Reconciliation of U.S. GAAP Net Income to Non-GAAP Net Income (in thousands, except per share data) (unaudited) Three Months Ended March 26, 2023 December 25, 2022 U.S. GAAP net income $ 814,008 $ 1,468,507 Pre-tax non-GAAP items: Amortization related to intangible assets acquired through certain business combinations - cost of goods sold 3,093 2,521 Elective deferred compensation ("EDC") related liability valuation increase - cost of goods sold 1,498 2,853 Restructuring charges, net - cost of goods sold 66,720 — Product rationalization - cost of goods sold 26,842 — Transformational costs - cost of goods sold 558 — EDC related liability valuation increase - research and development 2,697 5,136 Product rationalization - research and development 3,858 — Amortization related to intangible assets acquired through certain business combinations - selling, general and administrative 1,395 1,279 EDC related liability valuation increase - selling, general and administrative 1,798 3,424 Product rationalization - selling, general and administrative 2,891 — Transformational costs - selling, general and administrative 2,692 — Restructuring charges, net – operating expenses 40,408 — Amortization of note discounts - other income (expense), net 718 712 Gain on EDC related asset - other income (expense), net (5,443) (10,871) Net income tax benefit on non-GAAP items (17,250) (1,213) Net income tax benefit associated with legal entity restructuring — (11,773) Non-GAAP net income $ 946,483 $ 1,460,575 Non-GAAP net income per diluted share $ 6.99 $ 10.71 U.S. GAAP net income per diluted share $ 6.01 $ 10.77 U.S. GAAP and non-GAAP number of shares used for per diluted share calculation 135,395 136,339 Appendix – reconciliation -- 18 of 24 -- L A M R E S E A R C H Confidential – Limited Access and Use Three Months Ended March 26, 2023 December 25, 2022 U.S. GAAP gross margin $ 1,605,612 $ 2,376,349 Pre-tax non-GAAP items: Amortization related to intangible assets acquired through certain business combinations 3,093 2,521 EDC related liability valuation increase 1,498 2,853 Restructuring charges, net 66,720 — Product rationalization 26,842 — Transformational costs 558 — Non-GAAP gross margin $ 1,704,323 $ 2,381,723 U.S. GAAP gross margin as a percentage of revenue 41.5 % 45.0 % Non-GAAP gross margin as a percentage of revenue 44.0 % 45.1 % U.S. GAAP operating expenses $ 663,359 $ 696,187 Pre-tax non-GAAP items: Amortization related to intangible assets acquired through certain business combinations (1,395) (1,279) EDC related liability valuation increase (4,495) (8,560) Restructuring charges, net (40,408) — Product rationalization (6,749) — Transformational costs (2,692) — Non-GAAP operating expenses $ 607,620 $ 686,348 U.S. GAAP operating income $ 942,253 $ 1,680,162 Non-GAAP operating income $ 1,096,703 $ 1,695,375 U.S. GAAP operating income as percent of revenue 24.4 % 31.8 % Non-GAAP operating income as a percent of revenue 28.3 % 32.1 % Appendix – reconciliation Reconciliation of U.S. GAAP Gross Margin, Operating Expenses and Operating Income to Non-GAAP Gross Margin, Operating Expenses and Operating Income (in thousands, except percentages) (unaudited) -- 19 of 24 -- L A M R E S E A R C H Confidential – Limited Access and Use Three Months Ended March 26, 2023 December 25, 2022 U.S. GAAP Other income (expense), net $ (3,331) $ (28,234) Pre-tax non-GAAP items: Amortization of note discounts 718 712 Gain on EDC related asset (5,443) (10,871) Non-GAAP Other income (expense), net $ (8,056) $ (38,393) Appendix – reconciliation Reconciliation of U.S. GAAP Other Income (Expense), Net to Non-GAAP Other Income (Expense), Net (in thousands) (unaudited) -- 20 of 24 -- L A M R E S E A R C H Confidential – Limited Access and Use Three Months Ended March 26, 2023 December 25, 2022 U.S. GAAP income before income taxes $ 938,922 $ 1,651,928 U.S. GAAP income tax expense $ 124,914 $ 183,421 U.S. GAAP income tax rate 13.3 % 11.1 % Pre-tax non-GAAP items: Amortization related to intangible assets acquired through certain business combinations - cost of goods sold $ 3,093 $ 2,521 Elective deferred compensation ("EDC") related liability valuation increase - cost of goods sold 1,498 2,853 Restructuring charges, net - cost of goods sold 66,720 — Product rationalization - cost of goods sold 26,842 — Transformational costs - cost of goods sold 558 — EDC related liability valuation increase - research and development 2,697 5,136 Product rationalization - research and development 3,858 — Amortization related to intangible assets acquired through certain business combinations - selling, general and administrative 1,395 1,279 EDC related liability valuation increase - selling, general and administrative 1,798 3,424 Product rationalization - selling, general and administrative 2,891 — Transformational costs - selling, general and administrative 2,692 — Restructuring charges, net – operating expenses 40,408 — Amortization of note discounts - other income (expense), net 718 712 Gain on EDC related asset - other income (expense), net (5,443) (10,871) Non-GAAP income before taxes $ 1,088,647 $ 1,656,982 Net income tax benefit on non-GAAP items $ 17,250 $ 1,213 Net income tax benefit associated with legal entity restructuring $ — $ 11,773 Non-GAAP income tax expense $ 142,164 $ 196,407 Non-GAAP income tax rate 13.1 % 11.9 % Appendix – reconciliation Reconciliation of U.S. GAAP Income Tax Rate to Non-GAAP Income Tax Rate (in thousands, except percentages) (unaudited) -- 21 of 24 -- L A M R E S E A R C H Confidential – Limited Access and Use Three Months Ended March 26, 2023 U.S. GAAP net cash provided by operating activities $ 1,726,438 U.S. GAAP cash used for capital expenditures and intangible assets $ (119,457) Total free cash flow $ 1,606,981 Appendix – reconciliation Calculation of Free Cash Flows (in thousands) (unaudited) -- 22 of 24 -- L A M R E S E A R C H Confidential – Limited Access and Use Reconciliation of U.S. GAAP to Non-GAAP Guidance for the quarter ended June 25, 2023 The information provided above is only an estimate of what the Company believes is realizable as of the date of this release and does not incorporate the potential impact of any business combinations, asset acquisitions, divestitures, restructuring, balance sheet valuation adjustments, financing arrangements, other investments, or other significant arrangements that may be completed or recognized after the date of this release, except as described below. U.S. GAAP to non-GAAP reconciling items provided include only those items that are known and can be estimated as of the date of this release. Actual results will vary from this model and the variations may be material. Reconciling items included above are as follows: • Gross margin as a percentage of revenue - amortization related to intangible assets acquired through business combinations, $3 million; restructuring charges, $20 million; product rationalization charges, $2 million; and transformational costs, $1 million, totaling $26 million. • Operating income as a percentage of revenue - amortization related to intangible assets acquired through business combinations, $4 million; restructuring charges, $21 million; transformational costs, $9 million; and product rationalization charges, $2 million; totaling $36 million. • Net income per diluted share - amortization related to intangible assets acquired though business combinations, $4 million; amortization of note discounts, restructuring charges, $21 million; transformational costs, $9 million; product rationalization charges, $2 million; amortization of debt discounts, $1 million; and associated tax benefit for non-GAAP items ($4 million); totaling $33 million. U.S. GAAP Reconciling Items Non-GAAP Revenue $3.1 Billion +/- $300 Million — $3.1 Billion +/- $300 Million Gross margin as a percentage of revenue 43.2% +/- 1% $ 26 Million 44.0% +/- 1% Operating income as a percentage of revenue 24.3% +/- 1% $ 36 Million 25.5% +/- 1% Net income per diluted share $4.75 +/- $0.75 $ 33 Million $5.00 +/- $0.75 Diluted share count 134 million — 134 million Appendix – reconciliation -- 23 of 24 -- -- 24 of 24 --